Hong Gi Kim Selected Research

CW-270033

3/2007

CW-270033, a novel pyrrolidinyl-thio carbapenem, has potent antimicrobial activity in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hong Gi Kim Research Topics

Disease

5	Infections 05/2022 - 03/2007
4	COVID-19 05/2022 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 01/2011 - 10/2007
1	Necrosis 03/2014
1	Hypertension (High Blood Pressure) 07/2011
1	Memory Disorders (Memory Loss) 01/2011
1	Nervous System Diseases (Neurological Disorders) 01/2011
1	Parkinson Disease (Parkinson's Disease) 01/2011
1	Mental Disorders (Mental Disorder) 10/2007
1	Anxiety Disorders (Anxiety Disorder) 10/2007
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 10/2007

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2010
2	Antiviral Agents (Antivirals)IBA 04/2021 - 01/2021
2	VaccinesIBA 01/2021 - 01/2020
2	AntigensIBA 01/2021 - 01/2020
1	Immunoglobulin G (IgG)IBA 05/2022
1	AntibodiesIBA 05/2022
1	Neutralizing AntibodiesIBA 05/2022
1	sarcoma-associated antigen S1IBA 01/2021
1	BoronIBA 03/2014
1	MecamylamineIBA 07/2011
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 07/2011
1	Neuropep-1IBA 01/2011
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2011
1	bacteriophage T7 RNA polymerase (T7 RNA polymerase)IBA 06/2010
1	Hormones (Hormone)IBA 10/2007
1	Meropenem (Merrem)FDA LinkGeneric 03/2007
1	CW-270033IBA 03/2007